Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?

被引:13
|
作者
Thatrimontrichai, Anucha [1 ]
Apisarnthanarak, Anucha [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Dept Pediat, Div Neonatol, Hat Yai, Thailand
[2] Thammasat Univ Hosp, Dept Med, Div Infect Dis, Pathum Thani 12120, Thailand
关键词
Active surveillance; Asymptomatic infections; Gram-negative bacteria; Infection control; Multidrug resistance; INTENSIVE-CARE UNITS; ACINETOBACTER-BAUMANNII COLONIZATION; SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; INFECTION; OUTBREAK; PREVENTION; BACTERIA; ENTEROBACTERIACEAE;
D O I
10.1016/j.jfma.2019.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing burden of multidrug-resistant gram-negative bacilli (MDR-GNB) infection has highlighted the urgent requirement for efficient prevention and control strategies. A routine active surveillance culture (ASC) program of asymptomatic carriers as part of an infection prevention strategy for MDR-GNB still has some controversy. An ASC program for colonized patients may be beneficial depending on the targeted population, level of endemicity, the species of pathogen, and the combination of multifaceted strategies. Multimodal infection control and prevention strategies are crucial for implementation in resources-limited settings. After discovering the culprit, it is a challenge to control MDR-GNB by containment or eradication and prevent cross-transmission. An ASC program should consider both the local epidemiology and cost-effectiveness based on the available resources in endemic MDR-GNB areas in the Asia-Pacific region. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:1581 / 1585
页数:5
相关论文
共 50 条
  • [41] Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents
    A. Provenzani
    A. R. Hospodar
    A. L. Meyer
    D. Leonardi Vinci
    E. Y. Hwang
    C. M. Butrus
    P. Polidori
    International Journal of Clinical Pharmacy, 2020, 42 : 1016 - 1025
  • [42] Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organisms
    Fischer, Doris
    Schloesser, Rolf L.
    Kempf, Volkhard A. J.
    Wichelhaus, Thomas A.
    Klingebiel, Thomas
    Philippi, Sabine
    Falgenhauer, Linda
    Imirzalioglu, Can
    Dahl, Udo
    Brandt, Christian
    Reinheimer, Claudia
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [43] The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities
    Fallon, Erin O'
    Pop-Vicas, Aurora
    Agata, Erika D'
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2009, 64 (01): : 138 - 141
  • [44] Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries
    Otter, J. A.
    Mutters, N. T.
    Tacconelli, E.
    Gikas, A.
    Holmes, A. H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (12) : 1057 - 1066
  • [45] Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organisms
    Doris Fischer
    Rolf L. Schlößer
    Volkhard A. J. Kempf
    Thomas A. Wichelhaus
    Thomas Klingebiel
    Sabine Philippi
    Linda Falgenhauer
    Can Imirzalioglu
    Udo Dahl
    Christian Brandt
    Claudia Reinheimer
    BMC Infectious Diseases, 19
  • [46] Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents
    Provenzani, A.
    Hospodar, A. R.
    Meyer, A. L.
    Leonardi Vinci, D.
    Hwang, E. Y.
    Butrus, C. M.
    Polidori, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (04) : 1016 - 1025
  • [47] Addressing the Emergence and Impact of Multidrug-Resistant Gram-Negative Organisms: A Critical Focus for the Next Decade
    Lautenbach, Ebbing
    Perencevich, Eli N.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (04): : 333 - 335
  • [48] Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection
    Li, Xueyong
    Zhang, Bingqing
    Cheng, Yu
    Chen, Maohua
    Lin, Hailing
    Huang, Binglin
    Que, Wancai
    Liu, Maobai
    Zhou, Lili
    Weng, Qinyong
    Zhang, Hui
    Qiu, Hongqiang
    PHARMACEUTICS, 2022, 14 (11)
  • [49] The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit
    Giuffre, Mario
    Geraci, Daniela M.
    Bonura, Celestino
    Saporito, Laura
    Graziano, Giorgio
    Insinga, Vincenzo
    Aleo, Aurora
    Vecchio, Davide
    Mammina, Caterina
    MEDICINE, 2016, 95 (10)
  • [50] Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in
    Kuo, Li-Kuo
    Chang, Hou-Tai
    Hsueh, Shun-Chung
    Liu, Min
    Hsieh, Po-Chuen
    Jean, Shio-Shin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (05) : 801 - 811